Want to join the conversation?
$FBHS said that sales and profit gains were strong across all segments in 2Q16. Home products market continued to grow at the positive pace that company expected. Heading into the second half of the year, $FBHS expects strong underlying demand, significant levels of construction activity and continued market momentum.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.